Ashraf O Oweis1, Sameeha A Alshelleh2, Nesreen Saadeh3, Mohamad I Jarrah4, Rasheed Ibdah4, Karem H Alzoubi5. 1. Division of Nephrology, Department of Medicine, Jordan University of Science and Technology, Irbid, Jordan. 2. Division of Nephrology, Department of Medicine, The University of Jordan, Amman, Jordan. 3. Department of Medicine, Jordan University of Science and Technology, Irbid, Jordan. 4. Division of Cardiology, Department of Medicine, Jordan University of Science and Technology, Irbid, Jordan. 5. Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
Abstract
INTRODUCTION: Contrast-induced acute kidney injury (CI-AKI) is a worldwide known complication related to the use of contrast media with either imaging or angiography; it carries its own complications and effect on both morbidity and mortality; early identification of patients at risk and addressing modifiable risk factors may help reducing risk for this disease and its complications. METHODS: This was a prospective observational study, where all patients admitted for cardiac catheterization between June 2015 and January 2016 were evaluated for CI-AKI. There were two study groups: contrast-induced acute kidney injury (CI-AKI) group, and noncontrast-induced acute kidney injury (non-CI-AKI) group. RESULTS: Patients (n = 202) were included and followed up for 4 years. Death and development of chronic kidney disease (CKD) need for another revascularization were the end points. The incidence of CI-AKI was 14.8%.In univariate analysis, age (P = 0.016) and serum albumin at admission (P = 0.001) were statistically significant predictors of overall death. Age (P = 0.002), HTN (P = 0.002), DM (P = 0.02), and the use of diuretics (P = 0.001) had a statistically significant impact on eGFR. The rate of recatheterization was not statistically significant between the two groups (61 (35.5%) for the non-CI-AKI vs. 12 (40%) for the other group; P = 0.63). Some inflammatory markers (NGAL P = 0.06, IL-19 P = 0.08) and serum albumin at admission P = 0.07 had a trend toward a statistically significant impact on recatheterization. Death (P = 0.66) and need for recatheterization (P = 0.63) were not statistically different between the 2 groups, while the rate of eGFR decline in for the CI-AKI was significant (P = 0.004). CONCLUSION: CI-AKI is a common complication post percutaneous catheterization (PCI), which may increase the risk for CKD, but not death or the need for recatheterization. Preventive measures must be taken early to decrease the morbidity.
INTRODUCTION: Contrast-induced acute kidney injury (CI-AKI) is a worldwide known complication related to the use of contrast media with either imaging or angiography; it carries its own complications and effect on both morbidity and mortality; early identification of patients at risk and addressing modifiable risk factors may help reducing risk for this disease and its complications. METHODS: This was a prospective observational study, where all patients admitted for cardiac catheterization between June 2015 and January 2016 were evaluated for CI-AKI. There were two study groups: contrast-induced acute kidney injury (CI-AKI) group, and noncontrast-induced acute kidney injury (non-CI-AKI) group. RESULTS: Patients (n = 202) were included and followed up for 4 years. Death and development of chronic kidney disease (CKD) need for another revascularization were the end points. The incidence of CI-AKI was 14.8%.In univariate analysis, age (P = 0.016) and serum albumin at admission (P = 0.001) were statistically significant predictors of overall death. Age (P = 0.002), HTN (P = 0.002), DM (P = 0.02), and the use of diuretics (P = 0.001) had a statistically significant impact on eGFR. The rate of recatheterization was not statistically significant between the two groups (61 (35.5%) for the non-CI-AKI vs. 12 (40%) for the other group; P = 0.63). Some inflammatory markers (NGAL P = 0.06, IL-19 P = 0.08) and serum albumin at admission P = 0.07 had a trend toward a statistically significant impact on recatheterization. Death (P = 0.66) and need for recatheterization (P = 0.63) were not statistically different between the 2 groups, while the rate of eGFR decline in for the CI-AKI was significant (P = 0.004). CONCLUSION: CI-AKI is a common complication post percutaneous catheterization (PCI), which may increase the risk for CKD, but not death or the need for recatheterization. Preventive measures must be taken early to decrease the morbidity.
Authors: Paul M Ridker; Jean G MacFadyen; Robert J Glynn; Wolfgang Koenig; Peter Libby; Brendan M Everett; Martin Lefkowitz; Tom Thuren; Jan H Cornel Journal: J Am Coll Cardiol Date: 2018-05-29 Impact factor: 24.094
Authors: Alex F Castro-Mejía; María E Ortega-Armas; Hernán Mejía-Rentería; Nieves Gonzalo; Pablo Salinas; Luis Nombela-Franco; María Del Trigo; Pilar Jiménez-Quevedo; Javier Escaned; Antonio Fernández-Ortiz; Carlos Macaya; Iván J Nuñez-Gil Journal: Catheter Cardiovasc Interv Date: 2019-07-26 Impact factor: 2.692
Authors: Chirag R Parikh; Caroline Liu; Maria K Mor; Paul M Palevsky; James S Kaufman; Heather Thiessen Philbrook; Steven D Weisbord Journal: Am J Kidney Dis Date: 2019-09-20 Impact factor: 8.860
Authors: Julian Yeoh; Nick Andrianopoulos; Christopher M Reid; Matias B Yudi; Garry Hamilton; Melaine Freeman; Samer Noaman; Ernesto Oqueli; Sandra Picardo; Angela Brennan; William Chan; Dion Stub; Stephen Duffy; Omar Farouque; Andrew Ajani; David J Clark Journal: Int J Cardiol Date: 2020-03-03 Impact factor: 4.164
Authors: Vincenzo Pasceri; Giuseppe Patti; Francesco Pelliccia; Carlo Gaudio; Giulio Speciale; Roxana Mehran; George D Dangas Journal: JACC Cardiovasc Interv Date: 2018-05-14 Impact factor: 11.195
Authors: Ramez Morcos; Michael Kucharik; Pirya Bansal; Haider Al Taii; Rupesh Manam; Joel Casale; Houman Khalili; Brijeshwar Maini Journal: Clin Med Insights Cardiol Date: 2019-11-01
Authors: Werner Ribitsch; Joerg H Horina; Franz Quehenberger; Alexander R Rosenkranz; Gernot Schilcher Journal: Sci Rep Date: 2019-11-15 Impact factor: 4.379